Jak2
|
Human bone marrow |
Tyrosine kinase in the JAK/STAT pathway |
A gain-of-function mutation in human Jak2V617F causes bone marrow cells to outcompete wild-type cells via increased cell cycling in a competitive transplantation assay. |
[122] |
RAS
|
Mammalian epithelia in vitro and in vivo |
Kinase regulating growth |
Epithelial cells over-expressing RASG12V—a gain-of-function mutation—are outcompeted by wild-type epithelia in EDAC. |
[123] |
Tp53
|
Mammalian epithelia in vitro and in vivo |
Tumor suppressor |
Epithelial cells expressing a dominant-negative Tp53 are outcompeted by wild-type epithelia in a process termed epithelial defense against cancer (EDAC). |
[125] |
PIK3CA
|
Mammalian esophagus |
Catalytic subunit of phosphoinositide 3-kinase (PI3K) |
Esophageal epithelial cells heterozygous for the gain-of-function mutation Pik3CAH1047R/+ outcompete wild-type esophageal cells via biased cell fate toward proliferation. |
[121] |
APC
|
Mammalian intestine |
Tumor suppressor |
APC-mutant intestinal stem cell (ISC) clones cause wild-type ISCs to differentiate, thereby outcompeting them and leading to intestinal tumor initiation. |
[44,45] |
YAP
|
Mammalian intestine |
Growth-promoting factor in the Hippo pathway |
Epithelial cells over-expressing YAP5SA—a gain-of-function mutation—are outcompeted by wild-type epithelia in EDAC. |
[124] |
YAP
|
Mammalian liver |
Growth-promoting factor in the Hippo pathway |
Elevating YAP activity in hepatocytes through the 5SA mutation can drive liver tumor growth, if YAP activity is not higher in neighboring hepatocytes. |
[126] |
Glial cell derived neurotrophic factor (GDNF)
|
Mammalian testis |
Secreted TGF-β ligand which is required for SSC niche maintenance |
Misexpression in SSCs produces malignant tumors with germline markers. |
[183] |